Tag: Essential medicines

Biden Team Pulls Proposed GPA Modification to Remove Medicines

The Biden trade team has reversed an order issued by former President Trump to remove essential medicines from U.S. coverage under the WTO Government Procurement Agreement (GPA). In an April 16 filing with the WTO, the United States withdrew

U.S. GPA Modification Proposal Moves to Arbitration

The European Union and seven other parties to the WTO Government Procurement Agreement (GPA) have, for the first time, requested the use of arbitration to resolve their objections to a proposed withdrawal of procurement from the Agreement. On March 26, they

Biden Team Supports US Proposal to Withdraw Medicines from GPA

When the Trump administration ended, one of the issues that it left for the incoming administration was its proposal to withdraw a broad list of medicines and related products from U.S. commitments under the WTO Government Procurement Agreement

Trump’s Buy American Legacy

During his term, President Trump issued a number of Buy American directives. Of those that proposed concrete action, two have been enshrined in U.S. regulations, one that would reduce U.S. commitments under international agreements is pending and another was

U.S. Proposes Removal of Essential Medicines from GPA: REVISED

On November 27, the U.S. Trade Representative (USTR) complied with President Trump’s directive to take steps to withdraw essential medicines, medical countermeasures and their critical inputs (“Essential Medicines”), identified by the Food and Drug

Buy American: FDA’s Essential Medicines List

On October 30th, the Food and Drug Administration (FDA) published a list of essential medicines, medical countermeasures and critical inputs to comply with the president’s August 6 executive order. The U.S. Trade Representative (USTR) must take action